196 related articles for article (PubMed ID: 22028872)
1. Efficient generation of iPS cells from skeletal muscle stem cells.
Tan KY; Eminli S; Hettmer S; Hochedlinger K; Wagers AJ
PLoS One; 2011; 6(10):e26406. PubMed ID: 22028872
[TBL] [Abstract][Full Text] [Related]
2. Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells.
Pasha Z; Haider HKh; Ashraf M
PLoS One; 2011; 6(8):e23667. PubMed ID: 21886809
[TBL] [Abstract][Full Text] [Related]
3. Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells.
Maffioletti SM; Gerli MF; Ragazzi M; Dastidar S; Benedetti S; Loperfido M; VandenDriessche T; Chuah MK; Tedesco FS
Nat Protoc; 2015 Jul; 10(7):941-58. PubMed ID: 26042384
[TBL] [Abstract][Full Text] [Related]
4. Myogenic specification of side population cells in skeletal muscle.
Asakura A; Seale P; Girgis-Gabardo A; Rudnicki MA
J Cell Biol; 2002 Oct; 159(1):123-34. PubMed ID: 12379804
[TBL] [Abstract][Full Text] [Related]
5. MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells.
Watanabe S; Hirai H; Asakura Y; Tastad C; Verma M; Keller C; Dutton JR; Asakura A
Stem Cells; 2011 Mar; 29(3):505-16. PubMed ID: 21425413
[TBL] [Abstract][Full Text] [Related]
6. Role of Zscan4 in secondary murine iPSC derivation mediated by protein extracts of ESC or iPSC.
Kwon YW; Paek JS; Cho HJ; Lee CS; Lee HJ; Park IH; Roh TY; Kang CM; Yang HM; Park YB; Kim HS
Biomaterials; 2015 Aug; 59():102-15. PubMed ID: 25956855
[TBL] [Abstract][Full Text] [Related]
7. Generation of Mouse-Induced Pluripotent Stem Cells by Lentiviral Transduction.
Liu X; Chen J; Firas J; Paynter JM; Nefzger CM; Polo JM
Methods Mol Biol; 2019; 1940():63-76. PubMed ID: 30788818
[TBL] [Abstract][Full Text] [Related]
8. Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7.
Darabi R; Perlingeiro RC
Methods Mol Biol; 2016; 1357():423-39. PubMed ID: 25403466
[TBL] [Abstract][Full Text] [Related]
9. Development of feeder-free culture systems for generation of ckit+sca1+ progenitors from mouse iPS cells.
Lin J; Fernandez I; Roy K
Stem Cell Rev Rep; 2011 Sep; 7(3):736-47. PubMed ID: 21188655
[TBL] [Abstract][Full Text] [Related]
10. Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming.
Khoo TS; Jamal R; Abdul Ghani NA; Alauddin H; Hussin NH; Abdul Murad NA
Stem Cell Rev Rep; 2020 Apr; 16(2):251-261. PubMed ID: 32016780
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors.
Bao L; He L; Chen J; Wu Z; Liao J; Rao L; Ren J; Li H; Zhu H; Qian L; Gu Y; Dai H; Xu X; Zhou J; Wang W; Cui C; Xiao L
Cell Res; 2011 Apr; 21(4):600-8. PubMed ID: 21221129
[TBL] [Abstract][Full Text] [Related]
12. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
[TBL] [Abstract][Full Text] [Related]
13. Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells.
Tanaka N; Kato H; Tsuda H; Sato Y; Muramatsu T; Iguchi A; Nakajima H; Yoshitake A; Senbonmatsu T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942642
[TBL] [Abstract][Full Text] [Related]
14. Making muscle: skeletal myogenesis
Chal J; Pourquié O
Development; 2017 Jun; 144(12):2104-2122. PubMed ID: 28634270
[TBL] [Abstract][Full Text] [Related]
15. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells.
Eminli S; Foudi A; Stadtfeld M; Maherali N; Ahfeldt T; Mostoslavsky G; Hock H; Hochedlinger K
Nat Genet; 2009 Sep; 41(9):968-76. PubMed ID: 19668214
[TBL] [Abstract][Full Text] [Related]
16. Purified mesenchymal stem cells are an efficient source for iPS cell induction.
Niibe K; Kawamura Y; Araki D; Morikawa S; Miura K; Suzuki S; Shimmura S; Sunabori T; Mabuchi Y; Nagai Y; Nakagawa T; Okano H; Matsuzaki Y
PLoS One; 2011 Mar; 6(3):e17610. PubMed ID: 21412425
[TBL] [Abstract][Full Text] [Related]
17. Functional myogenic engraftment from mouse iPS cells.
Darabi R; Pan W; Bosnakovski D; Baik J; Kyba M; Perlingeiro RC
Stem Cell Rev Rep; 2011 Nov; 7(4):948-57. PubMed ID: 21461712
[TBL] [Abstract][Full Text] [Related]
18. Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.
Chang G; Miao YL; Zhang Y; Liu S; Kou Z; Ding J; Chen DY; Sun QY; Gao S
PLoS One; 2010 Apr; 5(4):e10320. PubMed ID: 20436676
[TBL] [Abstract][Full Text] [Related]
19. Lineage-specific reprogramming as a strategy for cell therapy.
Darabi R; Perlingeiro RC
Cell Cycle; 2008 Jun; 7(12):1732-7. PubMed ID: 18583932
[TBL] [Abstract][Full Text] [Related]
20. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells.
Mizuno Y; Chang H; Umeda K; Niwa A; Iwasa T; Awaya T; Fukada S; Yamamoto H; Yamanaka S; Nakahata T; Heike T
FASEB J; 2010 Jul; 24(7):2245-53. PubMed ID: 20181939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
